Our Associate, Dr. Patrick Yeramian, has
over 20 years of experience with the clinical development of innovative
formulations, new chemical entities and biotechnology derived drugs including
integrated development plans and Phase I-IV clinical trials. Since 2000, Dr.
Yeramian has provided support and guidance to emergent companies in the US and
Europe to develop their global registration strategy and implement their US and
international clinical plans.
Please call us at
(954) 655-8746 or e-mail us at
firstname.lastname@example.org. We will promptly respond.